Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug

(CNBC) Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring sales. The Danish pharmaceutical company reported a 30% increase in sales (at constant exchange rates) for the first half of this year, while operating profit also rose 32%.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Comments are closed.